NASDAQ:OVAS OvaScience (OVAS) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free OVAS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.38▼$3.6350-Day Range$8.56▼$17.1052-Week Range$0.66▼$1.52Volume402,988 shsAverage Volume163,131 shsMarket Capitalization$126.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get OvaScience alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About OvaScience Stock (NASDAQ:OVAS)Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.Read More Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here OVAS Stock News HeadlinesFebruary 11, 2024 | benzinga.comGeneral Catalyst Group V LP's Net WorthDecember 7, 2023 | finance.yahoo.comGlobal In Vitro Fertilization Market Size To Worth USD 39.12 Billion By 2032 | CAGR of 5.5%April 27, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?November 4, 2023 | thestreet.comOvascience (OVAS) Stock Drops After Pricing Public OfferingJune 30, 2023 | finance.yahoo.comGlobal Retail Automation Market Size 2023-2027 | Drivers, Product Types, Applications, Growth Analysis and ForecastJune 27, 2023 | markets.businessinsider.comTMRW Life Sciences Names Louis Villalba Chief Executive OfficerJune 22, 2023 | marketwatch.comIVF Devices and Consumables Market Research Report 2023 Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030June 1, 2023 | finance.yahoo.comOcuTerra Appoints Bill Steinkrauss as Chief Financial OfficerApril 27, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.May 15, 2023 | marketwatch.comIVF Market Business Approaches by 2030April 14, 2023 | marketwatch.comResearch Shows: Semen Analysis Systems Market Growth, Share, Trends, Size, Revenue, Opportunities and Demand – 2030March 27, 2023 | marketwatch.comIVF Market Size and Forecast till 2031March 27, 2023 | marketwatch.comGlobal InVitro Fertilization (IVF) Market Size by Application (Male Infertility, Female Infertility) Forecast from 2023 to 2028March 27, 2023 | marketwatch.comDonor Egg IVF (In-Vitro Fertilization) Market Size, Share, Outlook and Forecast to 2031March 26, 2023 | marketwatch.comIVF Instruments Market 2023: Strategies of Top Players by 2029March 19, 2023 | marketwatch.comIVF Market- Industry Fluctuation till 2029March 14, 2023 | marketwatch.comIVF Devices and Consumables Market Application, Product, Sales and Forecast 2023-2028March 12, 2023 | marketwatch.comGlobal IVF Devices and Consumables Market Analysis By Type Technology End-Use By Region By Country and Forecast 2023 to 2030 By VMReportsFebruary 25, 2023 | marketwatch.comIVF Market Size 2023: Reliable Business Demand, and New Strategies Forecast 2028February 25, 2023 | marketwatch.comIn-Vitro Fertilization (IVF) Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028February 19, 2023 | marketwatch.comGlobal IVF Market Application, Product Segment, Analysis and Forecast 2023-2030 Report By VMReportsFebruary 19, 2023 | marketwatch.comInVitro Fertilization (IVF) Market is Booming Worldwide with Top Countries DataFebruary 18, 2023 | marketwatch.comGlobal In-Vitro Fertilization (IVF) Market 2023 Industry Trends, Regional Developments and Competitive Landscape Analysis Report 2030 By VMReportsJanuary 18, 2023 | marketwatch.comIVF Market Size: Overview, Share, Trends with Current Market Scenario, 2027December 22, 2022 | marketwatch.comDonor Egg IVF Treatment Market Growth and Global Share 2023 | Developing Regions, Emerging Trends and Industry Size Forecast to 2029December 16, 2022 | marketwatch.comIn Vitro Fertilization Market : Latest Trends, Size, Key Players, Revenue and Forecast 2028December 6, 2022 | marketwatch.comIVF Market Analysis Report 2023 Along with Statistics Figures, Forecasts till 2027See More Headlines Receive OVAS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OvaScience and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:OVAS CUSIPN/A CIK1544227 Webwww.ovascience.com Phone(734) 845-9000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-50,970,000.00 Net Margins-10,128.37% Pretax MarginN/A Return on Equity-47.06% Return on Assets-42.39% Debt Debt-to-Equity RatioN/A Current Ratio12.62 Quick Ratio12.62 Sales & Book Value Annual Sales$290,000.00 Price / Sales437.37 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / Book1.97Miscellaneous Outstanding Shares35,830,000Free FloatN/AMarket Cap$126.84 million OptionableNot Optionable Beta3.11 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesLouis J. ArcudiPresident, Chief Executive Officer & DirectorJennifer Minai-AzaryChief Financial & Accounting OfficerChristophe Arbet-EngelsChief Medical OfficerThomas HooverChief Business OfficerDenise Dorigo JonesVice President-Human ResourcesKey CompetitorsCitius PharmaceuticalsNASDAQ:CTXRRepare TherapeuticsNASDAQ:RPTXEmergent BioSolutionsNYSE:EBSKaryopharm TherapeuticsNASDAQ:KPTIGlycoMimeticsNASDAQ:GLYCView All Competitors OVAS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of OvaScience own? Based on aggregate information from My MarketBeat watchlists, some companies that other OvaScience investors own include Synergy Pharmaceuticals (SGYP), OPKO Health (OPK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Melinta Therapeutics (MLNT), Bausch Health Companies (BHC), Bed Bath & Beyond (BBBY), GW Pharmaceuticals (GWPH), (RLYP) (RLYP) and Trevena (TRVN). This page (NASDAQ:OVAS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OvaScience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
